<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Artemisinin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:13 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Artemisinin_files/filelist.xml  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Artemisinin_files/filelist.xml'" tppabs="http://www.vietstarse.com/duocthu/Documents/Artemisinin_files/filelist.xml">
<title>ARTEMISININ</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VIETSTAR</o:Author>
  <o:LastAuthor>Ghost</o:LastAuthor>
  <o:Revision>3</o:Revision>
  <o:TotalTime>2</o:TotalTime>
  <o:Created>2006-08-08T14:00:00Z</o:Created>
  <o:LastSaved>2006-08-08T14:19:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>997</o:Words>
  <o:Characters>5685</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>47</o:Lines>
  <o:Paragraphs>13</o:Paragraphs>
  <o:CharactersWithSpaces>6669</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.3pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:9.0pt;
	font-family:Tahoma;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.4pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.BodyText21, li.BodyText21, div.BodyText21
	{mso-style-name:"Body Text 21";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.cach0, li.cach0, div.cach0
	{mso-style-name:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.normal1, li.normal1, div.normal1
	{mso-style-name:normal1;
	mso-style-parent:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span
style='font-size:9.0pt;mso-bidi-font-size:15.0pt;line-height:150%;font-family:
Verdana'>ARTEMISININ<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=2 style='line-height:150%'><b><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Tên chung qu&#7889;c t&#7871;:</span></b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'> Artemisinin.<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><b><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Mã ATC: </span></b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Ch&#432;a có.<b><span style='mso-tab-count:2'>                    </span><o:p></o:p></b></span></p>

<p class=2 style='line-height:150%'><b><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Lo&#7841;i thu&#7889;c: </span></b><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>Thu&#7889;c ch&#7889;ng s&#7889;t rét.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;text-align:justify;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#7841;ng
thu&#7889;c và hàm l&#432;&#7907;ng<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Viên nén 250 mg; viên &#273;&#7841;n
250 mg, 500 mg.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;text-align:justify;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c
lý và c&#417; ch&#7871; tác d&#7909;ng<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Artemisinin là thu&#7889;c ch&#7889;ng
s&#7889;t rét, &#273;&#432;&#7907;c phân l&#7853;p t&#7915; cây Thanh hao hoa
vàng (<i>Artemisia annua</i> L.), h&#7885; <i>Asteriaceae</i>. Thu&#7889;c có
hi&#7879;u qu&#7843; cao, th&#7853;m chí c&#7843; v&#7899;i ký sinh trùng s&#7889;t
rét <i>Plasmodium falciparum </i>&#273;ã kháng cloroquin. Khác v&#7899;i các
thu&#7889;c ch&#7889;ng s&#7889;t rét hi&#7879;n &#273;ang dùng có c&#7845;u
trúc d&#7883; vòng ch&#7913;a nitrogen, artemisinin là m&#7897;t sesquiterpen
lacton có c&#7847;u n&#7889;i endoperoxid. C&#7847;u n&#7889;i này r&#7845;t
quan tr&#7885;ng &#273;&#7889;i v&#7899;i tác d&#7909;ng ch&#7889;ng s&#7889;t
rét c&#7911;a thu&#7889;c. Artemisinin có tác d&#7909;ng m&#7841;nh di&#7879;t
th&#7875; phân li&#7879;t, nh&#432;ng th&#7921;c t&#7871; không có tác d&#7909;ng
trên th&#7875; ngo&#7841;i h&#7891;ng c&#7847;u, th&#7875; thoa trùng và th&#7875;
giao t&#7917;.<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>C&#417; ch&#7871; tác d&#7909;ng c&#7911;a
artemisinin còn ch&#432;a bi&#7871;t th&#7853;t rõ. Thu&#7889;c t&#7853;p trung
ch&#7885;n l&#7885;c vào t&#7871; bào nhi&#7877;m ký sinh trùng và ph&#7843;n &#7913;ng
v&#7899;i hemin (hemozoin) trong ký sinh trùng. In vitro, ph&#7843;n &#7913;ng
này hình nh&#432; sinh ra các g&#7889;c h&#7919;u c&#417; t&#7921; do &#273;&#7897;c
h&#7841;i có th&#7875; phá h&#7911;y các màng c&#7911;a ký sinh trùng.<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Trong nhi&#7873;u th&#7917; nghi&#7879;m
lâm sàng t&#7841;i Trung Qu&#7889;c và Vi&#7879;t Nam, so sánh artemisinin v&#7899;i
nhi&#7873;u thu&#7889;c s&#7889;t rét khác, k&#7871;t qu&#7843; cho th&#7845;y
v&#7899;i artemisinin th&#7901;i gian c&#7855;t s&#7889;t và th&#7901;i gian s&#7841;ch
ký sinh trùng trong máu nhanh h&#417;n so v&#7899;i cloroquin, quinin,
mefloquin ho&#7863;c ph&#7889;i h&#7907;p mefloquin/ sulphadoxin/ pyrimethamin &#7903;
ng&#432;&#7901;i b&#7879;nh s&#7889;t rét do <i>P. falciparum</i> không bi&#7871;n
ch&#7913;ng. K&#7871;t qu&#7843; rõ nh&#7845;t là v&#7899;i s&#7889;t rét do <i>P.
falciparum </i>kháng cloroquin và bi&#7871;n ch&#7913;ng th&#7875; não c&#7843;
&#7903; ng&#432;&#7901;i l&#7899;n và tr&#7867; em. &#7902; 141 ng&#432;&#7901;i
b&#7879;nh th&#7875; não &#273;i&#7873;u tr&#7883; dùng u&#7889;ng qua &#7889;ng
thông ho&#7863;c tiêm b&#7855;p, t&#7927; l&#7879; t&#7917; vong là 7%. M&#7897;t
nghiên c&#7913;u t&#432;&#417;ng t&#7921; &#7903; tr&#7867; em d&#432;&#7899;i
15 tu&#7893;i, th&#7845;y t&#7927; l&#7879; t&#7917; vong là 9%. Nh&#7919;ng t&#7927;
l&#7879; này th&#7845;p h&#417;n so v&#7899;i t&#7927; l&#7879; &#273;&#432;&#7907;c
báo cáo trong m&#7897;t s&#7889; nghiên c&#7913;u khác s&#7917; d&#7909;ng
cloroquin ho&#7863;c quinin.<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>M&#7897;t trong nh&#7919;ng v&#7845;n
&#273;&#7873; ch&#7911; y&#7871;u c&#7911;a artemisinin và d&#7851;n xu&#7845;t
là t&#7927; l&#7879; tái phát cao trong vòng m&#7897;t tháng sau khi &#273;i&#7873;u
tr&#7883;, nên có khuynh h&#432;&#7899;ng ph&#7889;i h&#7907;p v&#7899;i
mefloquin &#273;&#7875; tránh tái phát s&#7899;m.<o:p></o:p></span></p>

<p class=5 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>D&#432;&#7907;c &#273;&#7897;ng h&#7885;c<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Artemisinin có th&#7875; dùng u&#7889;ng
ho&#7863;c &#273;&#7863;t h&#7853;u môn. Sau khi u&#7889;ng, artemisinin h&#7845;p
thu nhanh, n&#7891;ng &#273;&#7897; &#273;&#7881;nh &#273;&#7841;t &#273;&#432;&#7907;c
trong huy&#7871;t t&#432;&#417;ng trong vòng 1 gi&#7901;. S&#7921; h&#7845;p
thu qua tr&#7921;c tràng c&#7911;a h&#7895;n d&#7883;ch trong n&#432;&#7899;c
kém và thay &#273;&#7893;i so v&#7899;i dùng u&#7889;ng ho&#7863;c tiêm b&#7855;p
dung d&#7883;ch d&#7847;u. Sau khi &#273;&#7863;t h&#7853;u môn, li&#7873;u 10
mg/kg &#7903; ng&#432;&#7901;i, n&#7891;ng &#273;&#7897; trong máu c&#7911;a
artemisinin là 8,6 nanogam/ml sau 30 phút, và &#273;&#7841;t t&#7899;i n&#7891;ng
&#273;&#7897; t&#7889;i &#273;a trong máu kho&#7843;ng 110 nanogam/ml 6 gi&#7901;
sau khi dùng thu&#7889;c.<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Sau khi tiêm b&#7855;p,
artemisinin h&#7845;p thu ch&#7853;m h&#417;n chút ít so v&#7899;i khi u&#7889;ng
ho&#7863;c tiêm t&#297;nh m&#7841;ch, th&#7901;i gian bán th&#7843;i là 3,85 -
5,38 gi&#7901;. N&#7891;ng &#273;&#7897; &#273;&#7881;nh trong huy&#7871;t
t&#432;&#417;ng &#273;&#7841;t &#273;&#432;&#7907;c kho&#7843;ng 2 gi&#7901;
sau khi dùng.<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Sau khi tiêm t&#297;nh m&#7841;ch
artemisinin cho chu&#7897;t, th&#7845;y m&#7897;t l&#432;&#7907;ng &#273;áng k&#7875;
ch&#7845;t này trong não, ch&#7913;ng t&#7887; thu&#7889;c &#273;i qua
&#273;&#432;&#7907;c hàng rào máu - não. Ði&#7873;u này có th&#7875; có liên
quan &#273;&#7871;n tác d&#7909;ng c&#7911;a artemisinin &#273;&#7889;i v&#7899;i
s&#7889;t rét th&#7875; não.<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Artemisinin liên k&#7871;t m&#7841;nh
v&#7899;i protein huy&#7871;t t&#432;&#417;ng và v&#7899;i h&#7891;ng c&#7847;u
(hemoglobin). S&#7921; liên k&#7871;t v&#7899;i protein huy&#7871;t
t&#432;&#417;ng &#7903; ng&#432;&#7901;i là 64%. Thu&#7889;c phân b&#7889; r&#7845;t
r&#7897;ng vào c&#417; th&#7875; v&#7899;i th&#7875; tích phân b&#7889; &#7903;
chu&#7897;t c&#7889;ng tr&#7855;ng là 1,1 lít/kg. Th&#7921;c nghi&#7879;m cho
th&#7845;y gan là n&#417;i chuy&#7875;n hóa chính c&#7911;a artemisinin.<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Artemisinin b&#7883; th&#7911;y
phân nhanh trong c&#417; th&#7875; thành ch&#7845;t chuy&#7875;n hóa còn ho&#7841;t
tính là dihydroartemisinin. Ng&#432;&#7901;i u&#7889;ng artemisinin s&#7869;
cho 4 ch&#7845;t chuy&#7875;n hóa là deoxyartemisinin, deoxydihydroartemisinin,
dihydro - xydihydroartemisinin và m&#7897;t ch&#7845;t &#273;&#432;&#7907;c g&#7885;i
là crystal - 7 có th&#7875; phân l&#7853;p &#273;&#432;&#7907;c &#7903; n&#432;&#7899;c
ti&#7875;u. Các ch&#7845;t này &#273;&#7873;u không có nhóm peroxid và &#273;&#7873;u
không còn ho&#7841;t tính trên ký sinh trùng.<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana;letter-spacing:.2pt'>80% li&#7873;u
dùng &#273;&#432;&#7907;c th&#7843;i qua phân và n&#432;&#7899;c ti&#7875;u
trong vòng 24 gi&#7901;. Sau khi tiêm t&#297;nh m&#7841;ch cho chu&#7897;t c&#7889;ng
tr&#7855;ng và th&#7887;, th&#7901;i gian bán th&#7843;i trong huy&#7871;t
t&#432;&#417;ng c&#7911;a</span><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'> artemisinin kho&#7843;ng 30 phút,
còn c&#7911;a dihydroartemisinin là 5 - 21 gi&#7901;. Ch&#7881; m&#7897;t
l&#432;&#7907;ng r&#7845;t nh&#7887; artemisinin &#273;&#432;&#7907;c th&#7843;i
nguyên d&#7841;ng qua n&#432;&#7899;c ti&#7875;u.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;text-align:justify;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7881;
&#273;&#7883;nh<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana;letter-spacing:.1pt'>Ði&#7873;u tr&#7883;
s&#7889;t rét do t&#7845;t c&#7843; các lo&#7841;i <i>Plasmodium</i>, k&#7875;
c&#7843; s&#7889;t rét n&#7863;ng do ch&#7911;ng <i>P. falciparum</i> &#273;a
kháng. Artemisinin có hi&#7879;u qu&#7843; trong &#273;i&#7873;u tr&#7883; s&#7889;t
rét, nh&#432;ng ch&#7881; dùng khi các thu&#7889;c ch&#7889;ng s&#7889;t rét
khác không có tác d&#7909;ng và ph&#7843;i dùng &#273;&#7911; li&#7873;u</span><span
style='font-size:9.0pt;mso-bidi-font-size:14.0pt;line-height:150%;font-family:
Verdana'>.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;text-align:justify;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ch&#7889;ng
ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ch&#432;a &#273;&#432;&#7907;c bi&#7871;t
rõ.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;text-align:justify;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7853;n
tr&#7885;ng<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ch&#432;a th&#7845;y có báo cáo v&#7873;
v&#7845;n &#273;&#7873; này. Tuy v&#7853;y, v&#7851;n c&#7847;n th&#7853;n tr&#7885;ng
khi dùng.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;text-align:justify;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; mang thai<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Kinh nghi&#7879;m &#7903; ng&#432;&#7901;i
còn h&#7841;n ch&#7871;, &#273;&#7863;c bi&#7879;t là trong giai &#273;o&#7841;n
&#273;&#7847;u c&#7911;a thai k&#7923;. Nghiên c&#7913;u trên 23 ng&#432;&#7901;i
mang thai &#273;&#432;&#7907;c 16 - 38 tu&#7847;n dùng artemisinin, tr&#7867;
&#273;&#7867; ra không th&#7845;y có tác d&#7909;ng ph&#7909; có h&#7841;i. Do
&#273;ó, có th&#7875; dùng artemisinin cho ng&#432;&#7901;i mang thai b&#7883;
s&#7889;t rét th&#7875; não ho&#7863;c s&#7889;t rét có bi&#7871;n ch&#7913;ng &#7903;
vùng mà <i>P. falciparum</i> &#273;ã kháng nhi&#7873;u thu&#7889;c.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;text-align:justify;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Th&#7901;i
k&#7923; cho con bú<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Hi&#7879;n còn ch&#432;a bi&#7871;t
thu&#7889;c có ti&#7871;t vào s&#7919;a m&#7865; hay không. Tuy nhiên, nên ng&#7915;ng
cho tr&#7867; bú khi &#273;ang ph&#7843;i &#273;i&#7873;u tr&#7883; b&#7857;ng
artemisinin.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;text-align:justify;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Tác d&#7909;ng
không mong mu&#7889;n (ADR)<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Hàng tri&#7879;u ng&#432;&#7901;i
&#273;ã dùng artemisinin, nh&#432;ng ch&#432;a th&#7845;y có khuy&#7871;n cáo v&#7873;
các ph&#7843;n &#7913;ng có h&#7841;i nghiêm tr&#7885;ng. Các tác d&#7909;ng có
h&#7841;i th&#432;&#7901;ng là nh&#7865; và thoáng qua, g&#7891;m tác h&#7841;i
trên h&#7879; tiêu hóa (nh&#432; bu&#7891;n nôn, nôn, &#273;au b&#7909;ng, tiêu
ch&#7843;y), nh&#7913;c &#273;&#7847;u, chóng m&#7863;t, hoa m&#7855;t, &#273;&#7863;c
bi&#7879;t là sau khi u&#7889;ng. Nh&#7919;ng c&#417;n s&#7889;t ng&#7855;n do
thu&#7889;c c&#361;ng &#273;ã &#273;&#432;&#7907;c báo cáo trong m&#7897;t vài
nghiên c&#7913;u. Dùng &#273;&#432;&#7901;ng h&#7853;u môn, ng&#432;&#7901;i b&#7879;nh
có th&#7875; b&#7883; &#273;au mót, &#273;au b&#7909;ng và tiêu ch&#7843;y.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;text-align:justify;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>H&#432;&#7899;ng
d&#7851;n cách x&#7917; trí ADR<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>V&#7845;n &#273;&#7873; c&#7847;n
thi&#7871;t là ng&#432;&#7901;i b&#7879;nh ph&#7843;i dùng &#273;&#7911; li&#7873;u
&#273;&#7875; tránh tái phát.<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>N&#7871;u b&#7883; s&#7889;t rét n&#7863;ng,
có th&#7875; kéo dài &#273;&#7907;t &#273;i&#7873;u tr&#7883; &#273;&#7871;n 7
ngày. Th&#432;&#7901;ng dùng artemisinin khi các thu&#7889;c ch&#7889;ng s&#7889;t
rét khác không có hi&#7879;u qu&#7843;.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;text-align:justify;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Li&#7873;u
l&#432;&#7907;ng và cách dùng<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Viên nén: Viên thu&#7889;c có th&#7875;
nhai và nu&#7889;t mà không có v&#7883; khó ch&#7883;u. Li&#7873;u ng&#432;&#7901;i
l&#7899;n và tr&#7867; trên 6 tháng nh&#432; sau:<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ngày 1: 25 mg/kg, dùng m&#7897;t l&#7847;n
duy nh&#7845;t.<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ngày 2: 12,5 mg/kg, dùng m&#7897;t
l&#7847;n duy nh&#7845;t c&#7897;ng v&#7899;i mefloquin d&#7841;ng base 15 - 25
mg/kg.<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Ngày 3: 12,5 mg/kg, dùng m&#7897;t
l&#7847;n duy nh&#7845;t.<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana;letter-spacing:-.1pt'>&#7902; Vi&#7879;t
Nam, li&#7873;u artemisinin cho ng&#432;&#7901;i l&#7899;n nh&#432; sau: Ngày
1: 1000 mg (4 viên) chia làm 2 l&#7847;n. Sau &#273;ó 500 mg/ngày, trong 4 ngày
liên ti&#7871;p.<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Viên &#273;&#7841;n: Ng&#432;&#7901;i
l&#7899;n: Ngày 1: 1250 mg chia làm hai l&#7847;n. Sau &#273;ó 750 mg/ngày,
trong 2 - 3 ngày liên ti&#7871;p.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;text-align:justify;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng
tác thu&#7889;c<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Có hi&#7879;p &#273;&#7891;ng tác
d&#7909;ng gi&#7919;a artemisinin và mefloquin ho&#7863;c tetracyclin c&#7843;
trên <i>in vitro</i> v&#7899;i <i>P. falciparum</i> và<i> in vivo</i> v&#7899;i
<i>P. berghei</i>. S&#7921; ph&#7889;i h&#7907;p gi&#7919;a artemisinin v&#7899;i
cloroquin ho&#7863;c cloroquin v&#7899;i pyrimethamin có tính ch&#7845;t &#273;&#7889;i
kháng <i>in vitro</i> ch&#7889;ng l&#7841;i <i>P. falciparum</i>. <o:p></o:p></span></p>

<p class=3 style='margin-top:0in;text-align:justify;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>T&#432;&#417;ng
k&#7925;<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Artemisinin có th&#7875; ph&#7889;i
h&#7907;p v&#7899;i các thu&#7889;c ch&#7889;ng s&#7889;t rét khác, &#273;&#7863;c
bi&#7879;t là v&#7899;i mefloquin ho&#7863;c v&#7899;i sulfadoxin và
pyrimethamin.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;text-align:justify;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Ð&#7897;
&#7893;n &#273;&#7883;nh và b&#7843;o qu&#7843;n<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>B&#7843;o qu&#7843;n &#7903;
n&#417;i mát, &#273;&#7891; &#273;&#7921;ng &#273;&#7853;y nút kín, tránh ánh
sáng. <o:p></o:p></span></p>

<p class=3 style='margin-top:0in;text-align:justify;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Quá li&#7873;u
và x&#7917; trí <o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana'>Trong tr&#432;&#7901;ng h&#7907;p
quá li&#7873;u, c&#7847;n &#273;i&#7873;u tr&#7883; kh&#7849;n c&#7845;p theo
tri&#7879;u ch&#7913;ng nhi&#7877;m &#273;&#7897;c &#7903; các phòng c&#7845;p
c&#7913;u chuyên khoa. Ch&#432;a có thu&#7889;c gi&#7843;i &#273;&#7897;c
&#273;&#7863;c hi&#7879;u.<o:p></o:p></span></p>

<p class=3 style='margin-top:0in;text-align:justify;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'>Thông
tin quy ch&#7871;<o:p></o:p></span></p>

<p class=2 style='line-height:150%'><span style='font-size:9.0pt;mso-bidi-font-size:
14.0pt;line-height:150%;font-family:Verdana;letter-spacing:-.1pt'>Artemisinin
có trong Danh m&#7909;c thu&#7889;c thi&#7871;t y&#7871;u Vi&#7879;t Nam ban
hành l&#7847;n th&#7913; t&#432; n&#259;m 1999.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='mso-bidi-font-size:14.0pt;line-height:150%;font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Artemisinin.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:06:13 GMT -->
</html>
